PUBLIC STRATEGIES WASHINGTON, INC.

Lobbying for BIOTECHNOLOGY INDUSTRY ORGANIZATION · Biotechnology Trade Association

Filing 4th Quarter - Termination Amendment

4th Quarter (Oct 1 - Dec 31) 2024 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 28, 2026

Lobbying activity 4

Medicare/Medicaid

Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.

Trade (domestic/foreign)

Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.

Taxation/Internal Revenue Code

Issues relating to tax provisions covering the pharmaceutical and biologic industries.

Consumer Issues/Safety/Products

Monitor legislative proposals relating to data privacy and security

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.